![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
ASH 2019 updates on Minimal Residual Disease (MRD) - Italian (Myeloma Patients Europe) View |
![]() |
ASH 2019 updates on Minimal Residual Disease (MRD) (Myeloma Patients Europe) View |
![]() |
Sabina Chiaretti, ASH 2019: Blinatumomab in Relapsed/Refractory Adult ALL (Touch Medical Media) View |
![]() |
Highlights from IMW 2019 Part I (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Highlights from iwCLL 2019: MRD and novel therapies (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients Enrolled in the Forte Trial (International Myeloma Foundation) View |
![]() |
FORTE trial: Impact of minimal residual disease on multiple myeloma patients (ecancer) View |
![]() |
Claudio Cerchione on the 2nd SOHO Italy meeting (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Multiple myeloma highlights from ASH 2019 (ecancer) View |
![]() |
Robin Foà, ASH 2018 – Developments in the treatment of haematological malignancies (Touch Medical Media) View |